Evaluation of the Use of an E-health Therapeutic Education Application for Osteoarthritis Patients (ARTHe 2)

July 8, 2022 updated by: University Hospital, Clermont-Ferrand

Osteoarthritis is the most common joint disease affecting the joint in a comprehensive and progressive manner. It leads to increasing disability.

The recommendations of recent years favor the non-pharmacological treatment of osteoarthritis including regular physical activity, therapeutic education and weight loss Osteoarthritis population has a low level of physical activity due to a lack of information, motivation and false beliefs related to physical activity and kinesiophobia (fear of movement) A preliminary qualitative study (ARTHe1) evaluating the barriers and levers of the use of an e-health therapeutic education application in patients with osteoarthritis was carried out in order to guide the development of the ARTHe application.

The objective of this study is to have the application tested on a panel of patients in order to assess the benefits of using the application in terms of adherence to the practice of physical activity but also in clinical terms on function and pain, and the satisfaction of the patient

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a prospective observational study including the evaluation of the use of the ARTH-e application after 3 weeks, 6 weeks and 3 months of use.

Patient recruitment will be done in the PRM department of Clermont-Ferrand University Hospital A subgroup of patients will receive a Garmin VivoSmart 4 connected wristband, which will record intrinsic stress measurement data during the test.

Study Type

Observational

Enrollment (Actual)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aura
      • Clermont-Ferrand, Aura, France, 63000
        • Clermont-Ferrand University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient with knee arthritis and using a smartphone

Description

Inclusion Criteria:

  • Patients older than 18 years
  • Patients with osteoarthritis according to the ACR (American College of Rheumatology) criteria, symptomatic and diagnosed before inclusion by a specialist or not.
  • Patients with least one knee impairment
  • Patients with a smartphone or tablet with at least Android 5 or iOS 11.
  • Volunteer patients willing to participate in the study.

Exclusion Criteria:

  • Patients with no diagnostic criteria for ACR.
  • Patients with comprehension disorders making it impossible to interview and complete questionnaires or use the application.
  • Refusal to participate or being already included in a research protocol that could influence the current protocol.
  • Patients under guardianship, curatorship or deprived of liberty.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Excercie adherence
Time Frame: 3 weeks
Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree
3 weeks
Excercie adherence
Time Frame: 6 weeks
Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree
6 weeks
Excercie adherence
Time Frame: 3 months
Measured with Exercice Adherence Rating Scale (EARS) on 5 point Likert scale, 0= totally agree, 5 = totally disagree
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain with analogic visual scale
Time Frame: 3 weeks, 6 weeks, 3 months
average pain of the 3 prior days, collected on phone interview with analogic visual scale (0 = no pain, 10 = maximum pain )
3 weeks, 6 weeks, 3 months
Functional evaluation
Time Frame: 3 weeks, 6 weeks, 3 months

Collected on the phone with Knee injury and Osteoarthritis Outcome Score (KOOS).

This questionnaire contains 17 statements answering the question "During the last eight days, what was your difficulty with each of the following activities?" ". The responses range from "absent" (0 points) to "extreme" (4 points). The maximum score is 68. A high score is predictive of functional degradation.

3 weeks, 6 weeks, 3 months
Satisfaction questionnaire
Time Frame: 3 months
Collection after 3 months of use, of the evaluation of the application via a quality questionnaire in 3 parts including the general user experience, closed questions on the user interface and open questions on user expectations, this questionnaire will be sent by email.
3 months
Frequency of opening the application per week
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Frequency of opening the application with on exercice session per week
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Time spent on the application at each opening
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Number of sessions carried out on a level before moving to the next level
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Rating of exercice session (out of 5 stars)
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Rate of positive responses to questionnaires true / false
Time Frame: From day 1 to 3 months
Collection of application usage parameters in a codified manner
From day 1 to 3 months
Average weekly pain level
Time Frame: From day 1 to 3 months
Average pain level will be asked on the application at most twice a week. Collection of application usage parameters in a codified manner
From day 1 to 3 months
Daily number of steps
Time Frame: From day 1 to 3 months
Collection of intrinsic activity data for a subgroup using a connected bracelet Garmin in vivo 4, in a codified manner
From day 1 to 3 months
Intensity of movement
Time Frame: From day 1 to 3 months
Intensity of movement per day using Metbolic Equivalebt Task (MET) scale will be collected for a subgroup using a connected bracelet Garmin in vivo 4, in a codified manner
From day 1 to 3 months
Daily heart rate
Time Frame: From day 1 to 3 months
Daily average, minimum and maximum heart rate will be collected for a subgroup using a connected bracelet Garmin in vivo 4, in a codified
From day 1 to 3 months
Daily heart variability
Time Frame: From day 1 to 3 months
Collection of intrinsic activity data for a subgroup using a connected bracelet Garmin in vivo 4, in a codified manner
From day 1 to 3 months
Daily energy expenditure in calories
Time Frame: From day 1 to 3 months
Daily energy expenditure in calories will be collected for a subgroup using a connected bracelet Garmin in vivo 4, in a codified manner
From day 1 to 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2022

Primary Completion (Actual)

July 7, 2022

Study Completion (Actual)

July 7, 2022

Study Registration Dates

First Submitted

February 10, 2021

First Submitted That Met QC Criteria

February 10, 2021

First Posted (Actual)

February 11, 2021

Study Record Updates

Last Update Posted (Actual)

July 11, 2022

Last Update Submitted That Met QC Criteria

July 8, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteo Arthritis Knee

Clinical Trials on Application ARTHe

3
Subscribe